Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||44.82 x 100|
|Ask||0.00 x 0|
|Day's Range||47.94 - 49.09|
|52 Week Range||38.05 - 50.22|
|PE Ratio (TTM)||21.18|
|Dividend & Yield||0.51 (1.04%)|
|1y Target Est||N/A|
Fresenius Medical's (FMS) Malaysian plant will strengthen the company's presence in the rapidly-growing market.
In addition to selling dialysis products, Fresenius Medical Care also offers dialysis treatment and associated laboratory services to patients through its network of 3,690 clinics.
In 1H17, Fresenius Medical Care (FMS) earned ~1.6 billion euros from the sale of dialysis products, which equals year-over-year growth of 8% on a reported basis.